The apolipoprotein A-V gene (APOA5) plays an important role in determining plasma triglyceride levels. We studied the effects of APOA5 polymorphisms on plasma triglyceride levels in Turks, a population with low levels of HDL cholesterol and a high prevalence of coronary artery disease. We found 15 polymorphisms, three of which were novel. Seven haplotype-tagging single nucleotide polymorphisms (SNPs) were chosen and genotyped in ∼3,000 subjects. The rare alleles of the -1464T>C, -1131T>C, S19W, and 1259T>C SNPs were significantly associated with increased triglyceride levels (19-86 mg/dl; P < 0.05) and had clear gene-dose effects. Haplotype analysis of the nine common APOA5 haplotypes revealed significant effects on triglyceride levels (P < 0.001). Detailed analysis of haplotypes clearly showed that the -1464T>C polymorphism had no effect by itself but was a marker for the -1131T> C, S19W, and 1259T>C polymorphisms. The -1131T> C and 1259T>C polymorphisms were in a strong but incomplete linkage disequilibrium and appeared to have independent effects. Thus, the APOA5 -1131T>C, S19W, and 1259T>C rare alleles were associated with significant increases in plasma triglyceride levels. At least one of these alleles was present in ∼40% of the Turks. Similar associations were observed for -1131T>C and S19W in white Americans living in San Francisco, California. Copyright ©2006 by the American Society for Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Hodoǧlugil, U., Tanyolaç, S., Williamson, D. W., Huang, Y., & Mahley, R. W. (2006). Apolipoprotein A-V: A potential modulator of plasma triglyceride levels in Turks. Journal of Lipid Research, 47(1), 144–153. https://doi.org/10.1194/jlr.M500343-JLR200
Mendeley helps you to discover research relevant for your work.